Piramal Pharma Limited (PPLPHARMA.BO)
INR 221.45
(2.07%)
INR 221.45
(2.07%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 13.05 Billion INR | 33.05% |
| 2022 | 8.46 Billion INR | -28.28% |
| 2021 | 12.1 Billion INR | 105.05% |
| 2020 | 6.11 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 4.19 Billion INR | 87.47% |
| 2024 Q1 | 2.04 Billion INR | -57.39% |
| 2023 Q1 | 1.85 Billion INR | -50.66% |
| 2023 FY | - INR | 33.05% |
| 2023 Q4 | 5.29 Billion INR | 54.13% |
| 2023 Q3 | 3.43 Billion INR | 2.96% |
| 2023 Q2 | 3.33 Billion INR | 80.49% |
| 2022 Q2 | 2.29 Billion INR | 111.24% |
| 2022 Q1 | 1.08 Billion INR | 222.55% |
| 2022 FY | - INR | -28.28% |
| 2022 Q4 | 3.75 Billion INR | 102.22% |
| 2022 Q3 | 1.85 Billion INR | -19.33% |
| 2021 Q2 | 2.3 Billion INR | 0.0% |
| 2021 FY | - INR | 105.05% |
| 2021 Q4 | -888 Million INR | -122.46% |
| 2021 Q3 | 3.95 Billion INR | 71.28% |
| 2020 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | -35.758% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 78.871% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | -90.232% |
| Granules India Limited | 8.6 Billion INR | -51.74% |
| Indoco Remedies Limited | 2.64 Billion INR | -393.205% |
| Achyut Healthcare Limited | 524 Thousand INR | -2491388.55% |
| Ajanta Pharma Limited | 12.56 Billion INR | -3.9% |
| Alkem Laboratories Limited | 24.19 Billion INR | 46.041% |
| Alpa Laboratories Limited | 86.12 Million INR | -15058.313% |
| Brooks Laboratories Limited | 41.72 Million INR | -31186.906% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | -453.946% |
| Bajaj HealthCare Limited | 444.51 Million INR | -2836.992% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -782.7% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 85.211% |
| Eris Lifesciences Limited | 6.98 Billion INR | -86.867% |
| FDC Limited | 4.4 Billion INR | -196.6% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | -15.089% |
| Gufic Biosciences Limited | 1.48 Billion INR | -781.832% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | -90.267% |
| Ipca Laboratories Limited | 13.29 Billion INR | 1.835% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -3936.171% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 15881.305% |
| Lasa Supergenerics Limited | -65.08 Million INR | 20160.541% |
| Laurus Labs Limited | 8 Billion INR | -63.07% |
| Lupin Limited | 36.96 Billion INR | 64.686% |
| Mankind Pharma Limited | 28.09 Billion INR | 53.531% |
| Medicamen Biotech Limited | 245.66 Million INR | -5214.418% |
| Medico Remedies Limited | 150.37 Million INR | -8581.722% |
| Megasoft Limited | 284.73 Million INR | -4485.17% |
| NATCO Pharma Limited | 18.79 Billion INR | 30.538% |
| RPG Life Sciences Limited | 1.28 Billion INR | -918.759% |
| Sigachi Industries Limited | 883.39 Million INR | -1377.862% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 90.564% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | -179.13% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -2934.192% |
| Unichem Laboratories Limited | 742.35 Million INR | -1658.644% |
| Wanbury Limited | 985.49 Million INR | -1224.762% |
| Windlas Biotech Limited | 781.72 Million INR | -1570.086% |
| ZIM Laboratories Limited | 462.09 Million INR | -2725.251% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 76.779% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 449.892% |
| Divi's Laboratories Limited | 25.43 Billion INR | 48.661% |
| Hester Biosciences Limited | 539.47 Million INR | -2320.042% |
| Procter & Gamble Health Limited | 3.01 Billion INR | -333.101% |
| Amrutanjan Health Care Limited | 682.53 Million INR | -1812.773% |
| Bal Pharma Limited | 345.59 Million INR | -3677.692% |
| Strides Pharma Science Limited | 3.76 Billion INR | -246.786% |
| Venus Remedies Limited | 711.8 Million INR | -1734.136% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | -233.947% |
| Nectar Lifesciences Limited | 1.56 Billion INR | -734.856% |
| Shilpa Medicare Limited | 2.58 Billion INR | -404.462% |
| Aarti Drugs Limited | 3.24 Billion INR | -301.874% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | -400.859% |
| Suven Life Sciences Limited | -992.78 Million INR | 1415.035% |
| Ind-Swift Limited | 1.06 Billion INR | -1125.783% |
| Valiant Laboratories Limited | 12.73 Million INR | -102383.711% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | -39.857% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 562.646% |
| Themis Medicare Limited | 562.6 Million INR | -2220.519% |
| Hikal Limited | 2.69 Billion INR | -384.929% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 62.709% |
| Sequent Scientific Limited | 549.8 Million INR | -2274.573% |
| Novartis India Limited | 1.26 Billion INR | -928.551% |
| Wockhardt Limited | 1.08 Billion INR | -1108.833% |
| Jubilant Pharmova Limited | 8 Billion INR | -63.07% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -99849.472% |
| Neuland Laboratories Limited | 4.74 Billion INR | -174.956% |
| Morepen Laboratories Limited | 1.72 Billion INR | -656.416% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -4442.194% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -7362.531% |